^
    CANCER:

    Germ Cell Tumors





    Show legend
    Group by Gene:
    Include preclinical:

    0
    Bifunctional alkylating agent
    ifosfamide
    1
    Topoisomerase II inhibitor
    etoposide IV
    2
    Topoisomerase II inhibitor, RNA synthesis inhibitor
    dactinomycin
    3
    PD1 inhibitor
    camrelizumab
    pembrolizumab
    4
    PARP inhibitor
    olaparib
    5
    mTOR inhibitor
    everolimus
    6
    EGFR inhibitor
    icotinib
    VIP
    EP
    BEP
    CaT
    		7
    Chemotherapy
    TI-CE
    GemOx
    VC
    VAC
    VeIP
    TIP
    8
    MEK inhibitor
    MEK inhibitor
    9
    Microtubule stabilizer, Tubulin polymerization promoter
    carboplatin + docetaxel
    docetaxel
    10
    Tubulin polymerization promoter, DNA synthesis inhibitor, Bcl2 inhibitor
    gemcitabine + paclitaxel
    11
    Tubulin polymerization promoter, Bcl2 inhibitor
    paclitaxel
    12
    Bifunctional alkylating agent, Tubulin polymerization promoter, Bcl2 inhibitor
    paclitaxel + ifosfamide
    13
    Tubulin polymerization promoter, DNA synthesis inhibitor, DNA cross linking agent, Bcl2 inhibitor
    gemcitabine + paclitaxel + oxaliplatin
    14
    Bifunctional alkylating agent, Topoisomerase II inhibitor, DNA inhibitor, DNA synthesis inhibitor
    cisplatin + ifosfamide + etoposide oral
    15
    Topoisomerase II inhibitor, DNA inhibitor
    etoposide oral
    16
    DNA synthesis inhibitor
    cisplatin
    No biomarker
    MSI-H/dMMR
    BRCA2 mutation
    PMS2 mutation
    MTOR mutation
    TMB-H
    MSH6 mutation
    KRAS amplification
    EGFR L858R
    BRCA1 mutation
    BRCA1 expression
    Chr t(22)
    BAX underexpression
    XPA expression
    RAD51C expression
    TP53 mutation
    PLAC8 overexpression